The immunomodulatory role of IDO1-Kynurenine-NAD(+) pathway in switching cold tumor microenvironment in PDAC

por Anu, R. I., Shiu, Kai-Keen, Khan, Khurum Hayat
Publicado 2023

Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme

por Iveson, Timothy, Carter, Angela M., Shiu, Kai-Keen, Spooner, Clare, Stevens, Daniel, Mullamitha, Saifee
Publicado 2020

CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab

por Chen, Shih-Hsin, Edeline, Julien, Shiu, Kai-Keen, Benafif, Sarah, Wong, Sofia, Groves, Ashley, Bridgewater, John, Ganeshan, Balaji
Publicado 2015

Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience

por Joharatnam-Hogan, Nalinie, Wilson, William, Shiu, Kai Keen, Fusai, Giuseppe Kito, Davidson, Brian, Hochhauser, Daniel, Bridgewater, John, Khan, Khurum
Publicado 2020

Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer

por Morelli, Cristina, Formica, Vincenzo, Patrikidou, Anna, Rofei, Michela, Shiu, Kai Keen, Riondino, Silvia, Argirò, Renato, Floris, Roberto, Ferlosio, Amedeo, Orlandi, Augusto, Roselli, Mario, Arkenau, Hendrik-Tobias
Publicado 2022

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial

por Adams, Richard, Brown, Ewan, Brown, Louise, Butler, Rachel, Falk, Stephen, Fisher, David, Kaplan, Richard, Quirke, Phil, Richman, Susan, Samuel, Leslie, Seligmann, Jenny, Seymour, Matt, Shiu, Kai Keen, Wasan, Harpreet, Wilson, Richard, Maughan, Tim
Publicado 2017

Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience

por Joharatnam-Hogan, Nalinie, Hochhauser, Daniel, Shiu, Kai-Keen, Rush, Hannah, Crolley, Valerie, Wilson, William, Sharma, Anand, Muhammad, Aun, Anwar, Muhammad, Vasdev, Nikhil, Goldstein, Robert, Kantser, Ganna, Saha, Aramita, Raja, Fharat, Bridgewater, John, Khan, Khurum
Publicado 2020

COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study

por Crolley, Valerie E., Hanna, Daire, Joharatnam-Hogan, Nalinie, Chopra, Neha, Bamac, Ekin, Desai, Meera, Lam, Yuk-Chun, Dipro, Sabiq, Kanani, Ruhi, Benson, Jack, Wilson, William, Fox, Thomas A., Shiu, Kai-Keen, Forster, Martin, Bridgewater, John, Hochhauser, Daniel, Khan, Khurum
Publicado 2020

Functional characterization of the 19q12 amplicon in grade III breast cancers

por Natrajan, Rachael, Mackay, Alan, Wilkerson, Paul M, Lambros, Maryou B, Wetterskog, Daniel, Arnedos, Monica, Shiu, Kai-Keen, Geyer, Felipe C, Langerød, Anita, Kreike, Bas, Reyal, Fabien, Horlings, Hugo M, van de Vijver, Marc J, Palacios, Jose, Weigelt, Britta, Reis-Filho, Jorge S
Publicado 2012

Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial

por Adams, Richard A., Fisher, David J., Graham, Janet, Seligmann, Jenny F., Seymour, Matthew, Kaplan, Richard, Yates, Emma, Parmar, Mahesh, Richman, Susan D., Quirke, Philip, Butler, Rachel, Brown, Ewan, Collinson, Fiona, Falk, Stephen, Wasan, Harpreet, Shiu, Kai-Keen, Middleton, Gary, Samuel, Leslie, Wilson, Richard H., Brown, Louise C., Maughan, Timothy S.
Publicado 2021

Pembrolizumab in Asian patients with microsatellite‐instability‐high/mismatch‐repair‐deficient colorectal cancer

por Yoshino, Takayuki, Andre, Thierry, Kim, Tae Won, Yong, Wei Peng, Shiu, Kai‐Keen, Jensen, Benny Vittrup, Jensen, Lars Henrik, Punt, Cornelis J. A., Smith, Denis, Garcia‐Carbonero, Rocio, Alcaide‐Garcia, Julia, Gibbs, Peter, de la Fouchardiere, Christelle, Rivera, Fernando, Elez, Elena, Le, Dung T., Adachi, Noriaki, Fogelman, David, Marinello, Patricia, Diaz, Luis A.
Publicado 2022

Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts

por Bortolomeazzi, Michele, Keddar, Mohamed Reda, Montorsi, Lucia, Acha-Sagredo, Amelia, Benedetti, Lorena, Temelkovski, Damjan, Choi, Subin, Petrov, Nedyalko, Todd, Katrina, Wai, Patty, Kohl, Johannes, Denner, Tamara, Nye, Emma, Goldstone, Robert, Ward, Sophia, Wilson, Gareth A., Al Bakir, Maise, Swanton, Charles, John, Susan, Miles, James, Larijani, Banafshe, Kunene, Victoria, Fontana, Elisa, Arkenau, Hendrik-Tobias, Parker, Peter J., Rodriguez-Justo, Manuel, Shiu, Kai-Keen, Spencer, Jo, Ciccarelli, Francesca D.
Publicado 2021